Liza Samir Samy

Dr. Liza Samir Samy

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Chemistry
Verified
Journal Article
Open access
PDF file
Dina AboushadyDina Aboushady
Dina Aboushady
LSLiza Samir Samy
Liza Samir Samy
Alaa Ahmed MasoudAlaa Ahmed Masoud
Alaa Ahmed Masoud
YEYasmin Zenhom Elshoura
Yasmin Zenhom Elshoura
Abdelgawad M.AbdelgawadAbdelgawad M.Abdelgawad
Abdelgawad M.Abdelgawad
Sami El DeebSami El Deeb
Sami El Deeb
Chemometrics, which applies mathematical and statistical methods to aid in experimental design, data analysis, and process optimization, is gaining more importance. It plays an important role in enhancing the sustainability of analytical methods when integrated with green analytical chemistry. Applying chemometrics to liquid chromatographic methods can speed up the analytical method, saving time, energy, and solvent consumption. This would be reflected by a low energy footprint and environmental impact. This review discusses the application of chemometric methods like multivariant data analysis, design of experiments, retention time prediction, and peak deconvolution in green liquid chromatographic analysis of pharmaceuticals. The review highlights the impact of chemometric approaches on the global push for sustainable practices. The integration of chemometrics into sustainable chromatographic analysis will continue to revolutionize the field leading to better performance of analytical methods.

5 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LSLiza Samir Samy
Liza Samir Samy
Rasha Sayed HanafiRasha Sayed Hanafi
Rasha Sayed Hanafi
Sami El DeebSami El Deeb
Sami El Deeb
HSHilde Spahn-langguth
Hilde Spahn-langguth
Carvedilol (CAR), a racemic lipophilic aryloxy propanolamine, acts as a selective α1-adrenoreceptor antagonist and a nonselective β-adrenoreceptor antagonist. CAR metabolism mainly produces three active metabolites: desmethyl carvedilol (DMC), 4′-hydroxy carvedilol (4′OHC) and 5′-hydroxy carvedilol (5′OHC). The oxidative S-(-)-metabolites contribute to the β-antagonistic effect, yet not to the α-antagonistic effect to be observed after drug dosage. Therefore, the three β-adrenoceptor blocking metabolites, which are structurally closely related to the parent CAR, are included into the development of a bioanalytical quantitative method for all major active species relevant with respect to adrenoceptor-blockade. Because of the given pharmacological profile, resolution of the enantiomers of carvedilol, of 4′- and 5′-hydroxy carvedilol as well as of DMC, is mandatory. The current study aims to determine the response surface for the enantiomer separation of the parent CAR as well as the major metabolites on a suitable chiral stationary phase. Design of experiment approach (DoE) was utilized in an initial screening phase followed by central-composite design for delimitation of the response surface for resolution of the four enantiomeric pairs in least run time. The impact of chromatographic variables (composition and percentage of organic modifier(s), buffer type, buffer pH, flow rate) on critical peaks resolution and adjusted retention time was evaluated, in order to select the most significant critical quality attributes. On this basis, a robust UHPLC-UV method was developed and optimized for the simultaneous, enantioselective determination of CAR along with its major active metabolites (4′OHC, 5′OHC, and DMC) on Chiralpak IBN-5. The optimized UHPLC-UV method (which includes metoprolol as the internal standard) was validated according to the ICH M10 guidelines for bioanalytical methods and proven to be linear, precise, accurate, and robust. The validated assay was applied to plasma samples from cardiovascular patients treated with rac-CAR (blood randomly drawn at different times after oral CAR intake). In order to provide more insight into the mechanism of the enantiomer separation of CAR and its metabolites on the CSP, docking experiments were performed. Molecular simulation studies suggest the chiral recognition to be mainly due to different binding poses of enantiomers of the same compound.

1 October 2023 in Analytica
Verified
Journal Article
Open access
PDF file
SSSara Shamseldin
Sara Shamseldin
LSLiza Samir Samy
Liza Samir Samy
SSSalem Eid Salem
Salem Eid Salem
SASahar Abdel-Maksoud
Sahar Abdel-Maksoud
Mohamed Zakaria GadMohamed Zakaria Gad
Mohamed Zakaria Gad
Rasha Sayed HanafiRasha Sayed Hanafi
Rasha Sayed Hanafi
The incidence of colorectal cancer (CRC) is increasing worldwide. It has variable signs and symptoms starting from changes in bowel habit to nausea and vomiting. Chemotherapeutic agents are often prescribed in CRC such as Capecitabine (CCB) and 5-Fluorouracil (FU). CCB is the prodrug of FU in oral dosage form, which makes it preferable by physicians, since no hospitalization is needed for drug administration. CCB is activated to FU in a three-step reaction producing 5′-deoxy-5-fluorocytidine (DFCR) (by carboxylesterase (CES) enzyme), then 5′-deoxy-5-fluorouridine (DFUR) (by cytidine deaminase (CDD) enzyme) and finally FU (by thymidine phosphorylase (TP) enzyme), the active form, which is later deactivated to give 5,6-dihydro-5-fluorouracil (DHFU). Different patients exhibit variable drug responses and adverse in response to CCB therapy, despite being treated by the same dose, which could be attributed to the occurrence of different possible enzyme single nucleotide polymorphisms (SNPs) along the activation and deactivation pathways of CCB. The most commonly occurring toxicities in CCB therapy are hand-foot syndrome and diarrhea. This study aims at developing and validating a new method for the simultaneous determination of CCB and its metabolites by HPLC-UV, followed by a correlation study with the toxicities occurring during therapy, where predictions of toxicity could be based on metabolites’ levels instead of the tedious process of genotyping. A new superior analytical method was optimized by a quality-by-design approach using DryLab® 2000 software achieving a baseline resolution of the six analytes within the least possible gradient time of 10 min. The method also showed linearity (in a range from 1 to 500 μg/mL), accuracy, precision and robustness upon validation: The LOD was found to be 3.0 ng/mL for DHFU and CCB, and 0.3 ng/mL for DFUR, DFCR and FU. The LOQ was found to be 10.0 ng/mL for DHFU and CCB, and 1.0 ng/mL for DFUR, DFCR and FU. The clinical results showed a positive correlation between the concentration of DFCR and mucositis and between the concentration of DFUR and hand-foot syndrome, confirming that this technique could be used for predicting such toxicities.

10 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Dina AboushadyDina Aboushady
Dina Aboushady
LSLiza Samir Samy
Liza Samir Samy
Alaa Ahmed MasoudAlaa Ahmed Masoud
Alaa Ahmed Masoud
YEYasmin Zenhom Elshoura
Yasmin Zenhom Elshoura
Abdelgawad M.AbdelgawadAbdelgawad M.Abdelgawad
Abdelgawad M.Abdelgawad
Sami El DeebSami El Deeb
Sami El Deeb
Chemometrics, which applies mathematical and statistical methods to aid experimental design, data analysis, and process optimization, is gaining more importance. It plays an important role in enhancing the sustainability of analytical methods when integrated with green analytical chemistry. Applying chemometrics to liquid chromatographic methods can speed up the analytical method, saving time, energy, and solvent consumption. This would be reflected by a low energy footprint and environmental impact. This review briefly discusses the application of chemometric methods like multivariant data analysis, design of experiment, retention time prediction, and peak deconvolution in green liquid chromatographic analysis of pharmaceuticals. The integration of chemometrics in sustainable chromatographic analysis will continue to revolutionize the field and further whitening analytical methods with better performance.

24 March 2026 in Plant Cell, Tissue and Organ Culture (PCTOC)
Verified
Journal Article
Open access
PDF file
ADAbeer F. Desouky
Abeer F. Desouky
SESalah El-Din El-Assal
Salah El-Din El-Assal
LSLiza Samir Samy
Liza Samir Samy
NGNancy D. Gergis
Nancy D. Gergis
Rasha Sayed HanafiRasha Sayed Hanafi
Rasha Sayed Hanafi
Moemen HanafyMoemen Hanafy
Moemen Hanafy
Catharanthus roseus (L.) G. Don is a key medicinal plant producing pharmacologically important terpenoid indole alkaloids (TIAs). This study aimed to enhance the biosynthesis of three major TIAs; catharanthine (CAT), vincristine (VCR), and vinblastine (VBL) through a stepwise in vitro approach involving callus culture, hairy roots (HRs) induction via Agrobacterium rhizogenes , and elicitation with zinc oxide (ZnO) and chitosan (CH) nanoparticles (NPs) in solid and liquid media. Two HR lines (L1, derived from K599/p35SGFPGUS⁺, and L2, from disarmed K599) and stem-derived calli were treated with 50 and 100 mg/L of ZnO- and CH-NPs. Nanoparticle treatments had limited effects on callus growth, except 100 mg/L CH-NPs, which reduced biomass in solid medium. In suspension culture, 50 mg/L ZnO-NPs enhanced fresh weight, whereas CH-NPs reduced it. Among HRs, the highest biomass occurred with 100 mg/L ZnO-NPs. HPLC analysis revealed higher VCR levels in cultured tissues than in field-grown leaves. In solid-grown HRs, CAT increased with 100 mg/L CH-NPs, and VCR rose significantly with 100 mg/L of either NP type. In liquid-grown HRs, CAT increased with 100 mg/L CH-NPs, VCR with 100 mg/L ZnO-NPs, and VBL with 50 mg/L CH-NPs. In callus cultures, ZnO-NPs promoted CAT and VCR accumulation in solid media, while VCR increased in suspension cultures treated with 100 mg/L ZnO-NPs or 50 mg/L CH-NPs. Gene expression analysis confirmed NP-induced modulation of STR , DAT , PRX1 , and SLS , correlating with alkaloid accumulation. Overall, ZnO and CH nanoparticles effectively elicited TIA biosynthesis in C. roseus cultures, highlighting their potential for enhanced alkaloid production.

28 February 2023 in Research Square
Verified
Preprint
Open access
PDF file
SSSara Shams
Sara Shams
LSLiza Samir Samy
Liza Samir Samy
SASahar Abdelmaksoud
Sahar Abdelmaksoud
MGMohamed Zakaria Gad
Mohamed Zakaria Gad
RHRasha Hanafi
Rasha Hanafi
The incidence of Colorectal cancer (CRC) is increasing worldwide. It has variable signs and symptoms starting from change in bowel habit to nausea and vomiting. Chemotherapeutic agents are often prescribed in CRC such as Capecitabine (CCB) and 5-Fluorouracil (FU). CCB is the prodrug of FU in oral dosage form, which makes it preferable by physicians, since no hospitalization is needed for drug administration. CCB is activated to FU in a 3-steps reaction producing 5'-deoxy-5-fluorocytidine (DFCR) (by carboxylesterase (CES) enzyme), then 5'-deoxy-5-fluorouridine (DFUR) (by cytidine deaminase (CDD) enzyme) and finally FU (by thymidine phosphorylase (TYMP) enzyme), the active form, which is later deactivated to give 5,6-dihydro-5-fluorouracil (DHFU). Different patients exhibit variable drug responses and adverse in response to CCB therapy, despite being treated by the same dose, which could be attributed tothe occurrence of different possible enzyme single nucleotide polymorphisms (SNPs) along the activation and deactivation pathways of CCB. The most commonly occurring toxicities in CCB therapy are Hand-Foot syndrome and diarrhea. This study aims at developing and validating a new method for simultaneous determination of CCB and its metabolites by HPLC-UV, followed by a correlation study with the toxicities occurring during therapy, where predictions of toxicity could be based on metabolites level instead ofthe tedious process of genotyping. A new superior analytical method was optimized by a Quality by Design approach using DryLab® software achieving baseline resolution of the 6 analytes within the least possible gradient time of 10 min. The method also showed linearity (in a range from 1 to 500 µg/ml), accuracy, precision and robustness upon validation. LOD was found to be 3 ng/mL for DHFU and CCB, and 0.3 ng/mL for DFUR, DFCR and FU. The LOQ was found to be 10 ng/mL for DHFU and CCB, and 1 ng/mL for DFUR, DFCR and FU. Clinical results showed a positive correlation between the concentration of DFCR and mucositis and between the concentration of DFUR and Hand-Foot Syndrome, confirming that this technique could be used for predicting such toxicities.